• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHL2500096 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(4) Generic Drug 2025-05-21 Sichuan Purity Pharmaceutical Co Ltd view
CYHL2500080 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2025-04-14 Chengdu Nuohe Shenghong Biopharmaceutical Co Ltd view
CYHL2500074 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(4) Generic Drug 2025-04-08 CF PharmTech Inc view
CYHS2404162 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2024-12-03 Reyoung Pharmaceutical Co Ltd view
JYHZ2400337 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs License Renew 2024-11-29 Siegfried Barbera SL;Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG view
JYHZ2400336 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs License Renew 2024-11-29 Siegfried Barbera SL;Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG view
JYHB2400605 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-11-19 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
JYHB2400606 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-11-19 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
CYHL2400227 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2024-11-15 Nanjing Zenkom Pharmaceutical Co Ltd view
JYHZ2400247 格隆溴铵福莫特罗吸入气雾剂 formoterol fumarate;glycopyrronium bromide Aerosol Chemical Drugs(5.1) License Renew 2024-09-19 AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Bespak HC Ltd view
CYHL2400130 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2024-06-26 Chengdu Nuohe Shenghong Biopharmaceutical Co Ltd view
JYHB2400277 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-06-13 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
JYHB2400278 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-06-13 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
CYHB2400395 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Supplementary Application 2024-03-19 Nantong No 3 Pharmaceutical Factory;Chengdu Hepatunn Pharmaceutical Co Ltd view
CYHL2300120 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2023-09-20 Zhejiang Fenghua Pharmaceutical Technology Co Ltd view
CYHL2300081 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(4) Generic Drug 2023-06-27 Respirent Pharmaceuticals Co Ltd view
JYHB2300339 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2023-06-19 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
JYHB2300340 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2023-06-19 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
CYHB2300982 格隆溴铵注射液 glycopyrronium bromide Injection Chemical Drugs(3) Supplementary Application 2023-05-07 Guangdong Jiabo Pharmaceutical Co Ltd view
JYHB2300164 格隆溴铵吸入粉雾剂 glycopyrronium bromide Powder for inhalation Chemical Drugs Supplementary Application 2023-03-07 Siegfried Barbera SL;Novartis Pharma Schweiz AG view